Navigation Links
JAMA article contends earlier study overstated validity of findings on bisphenol A
Date:2/18/2009

In a letter to be published in this week's Journal of the American Medical Association (JAMA), Dr. S. Stanley Young, Assistant Director of Bioinformatics at the National Institute of Statistical Sciences, and Ming Yu, University of British Columbia, highlight the statistical limitations of a study claiming that bisphenol A is associated with cardiovascular diagnoses, diabetes and abnormal blood level liver enzyme levels. The earlier study, published in JAMA (September 16, 2008) by Dr. Ian A. Lang and colleagues, did not adequately address the potential for multiple testing to result in a false positive result.

Young and Yu note that the CDC National Health and Nutrition Examination Survey [2003-2004] that was used in Lang et al's study measured 275 environmental chemicals and a wide range of health outcomes.

Although the Lang et al study focused on one chemical and 16 health outcomes, Young and Yu note that it is important to focus on how many questions were at issue. They point out that with 32 possible health outcomes, including combinations, potentially associated with any of the 275 chemicals, along with multiple confounders and statistical models, there could be as many as approximately 9 million statistical models available to analyze the data. Given the number of questions at issue and possible modeling variations in the CDC design, Young and Yu conclude that the findings reported by the authors could well be the result of chance rather than representing real health concerns.


'/>"/>

Contact: Jamie Nunnelly
nunnelly@niss.org
919-685-9319
National Institute of Statistical Sciences
Source:Eurekalert

Page: 1

Related medicine news :

1. Nanoparticle smart bomb targets drug delivery to cancer cells
2. JAMA Article Provides Guidance to Physicians on End-of-Life Care
3. LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects
4. PEGASYS(R) Proven Effective as Hepatitis C Treatment for Latino Patients, According to Article in The New England Journal of Medicine
5. Team Designs Gold Nanoparticles to Deliver Multiple Drugs
6. Gold nanoparticles for controlled drug delivery
7. Fresh Thinking: Harvard Business Review Article Explores When and How Companies Must Reinvent Their Businesses
8. Nontoxic nanoparticle can deliver and track drugs
9. Nanoparticles trigger cell death?
10. Nationally Recognized Diabetes Specialist Dr. Steven Edelman to Provide Educational Articles on Diabetes to MyCareTeam's Website Community
11. Free Article Now Available: 'Rights Expanding for Plaintiffs with In Utero Injuries'
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... to prep patients for colonoscopy at the HyGIeaCare® Center that is to be ... FL. , The HyGIeaCare® Prep, cleared by the U.S. Food and ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... first Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate ... during what is often a very difficult and challenging time.” , A Certified ...
(Date:3/24/2017)... ... ... Time GPS”: a dauntless and enlightened study of the second-coming of Christ, and ... published author, Wesley Gerboth, a World War II veteran, with a highly-regarded reputation as ... ninety-one, he shares the Wisdom God bestowed upon him in this publication. , ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... of inspiring stories about real people of God in congregations across the United ... Miller, a Presbyterian minister ordained in 1964 who has served congregations in seven ...
(Date:3/23/2017)... Greensboro, NC & Seattle, WA (PRWEB) , ... March 23, 2017 ... ... international public health emergency and now estimates that there could be four million Zika-related ... fastest growing epidemics to date with numbers of US cases reported per year skyrocketing ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets ... the U.S.: Consumer Strategies" report to their offering. ... Pain ... approach and treat their physical pain, emphasizing consumer survey analysis, ... pain sufferers and adults who have selected illnesses/conditions strongly associated ...
(Date:3/24/2017)... March 24, 2017 ShangPharma, a ... and cost-effective drug development and discovery services, ... biotechnology industry, announced today the intent for ... will be consolidating the Contract Research Organizations ... Shanghai ChemPartner. These entities include ChemPartner Shanghai, ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... offering. ... is very strong with a total of 97 drug candidates. Pharma giant ... are involved in the development of the IPF therapeutics. The IPF pipeline ... stage, 15 are in Phase II stage, 12 are in Phase I ...
Breaking Medicine Technology: